Your email has been successfully added to our mailing list.

×
-0.0907713289892409 -0.0907713289892409 -0.0907713289892409 -0.0907713289892409 -0.166540384906804 -0.136232762539779 -0.121078951356266 -0.120775875132596
Stock impact report

Matinas BioPharma Provides Comment on Impact of Vascepa® Patent Litigation on MAT9001 and Update on COVID-19 Pandemic’s Effect on Business Operations and Clinical Programs

Matinas Biopharma Holdings, Inc. (MTNB) 
NASDAQ:AMEX Investor Relations: ir.matinasbiopharma.com
Company Research Source: GlobeNewswire
BEDMINSTER, N.J., March 31, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today commented on the recent United States District Court decision to invalidate patents related to Amarin Corporation’s Vascepa and also provided an update on the effect of the rapidly evolving COVID-19 pandemic on its business operations and clinical development programs.  Impact of Invalidity Decision on Amarin Corporation’s Vascepa® Patents Matinas is aware of the United States District Court for the District of Nevada’s ruling yesterday in favor of the generic companies in Amarin Corporation’s patent litigation against two filers of abbreviated new drug applications, or ANDAs, for Amarin’s Vascepa.  Amarin issued a statement yesterday indicating that it will appeal and vigorously defend its intellectual property, while seeking an injunction to prevent a potential launch of generic versions of Vascepa.  In noting that an ANDA for Show less Read more
Impact Snapshot
Event Time:
MTNB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
MTNB alerts

from News Quantified
Opt-in for
MTNB alerts

from News Quantified